 |
| Clayface took the number-one spot at the box office this Halloween weekend. (AI-generated illustration) |
The October 23–25 weekend delivered the most interesting box office story of the fall: DC's R-rated body-horror film Clayface took #1 with $24 million domestic — while a three-hour A24 documentary about Elizabeth Holmes nearly stole the crown with $19.5 million in its second weekend, growing 28% when most films collapse. Add Laika's stop-motion Wildwood beating projections at #3, and you have a weekend that says a lot about what audiences actually want in late 2026.
And the timing couldn't be better: Halloween weekend (October 30) is here, with a 30th-anniversary Scream re-release, new horror arrivals, and a "dead zone" of new competition that could hand Clayface a second weekend at #1. This is your complete guide — the numbers, what they mean, what the weekend says about Hollywood's future, and what to watch this weekend, in theaters or at home.
For our full reviews of Clayface, see our Clayface full review, our Clayface spoiler-free review, and our Movies hub.
Key Takeaways
- Clayface opened #1 with $24M domestic (3,458 theaters) and $43–46.5M worldwide on a $30–44M budget — below tracking but profitable on its economics.
- A24's You Can See Everything surged 28% in weekend two to $19.5M, reaching $45.1M total on a ~$7M budget — the documentary is the real phenomenon.
- Laika's Wildwood opened to $11–11.6M, nearly doubling its $6–8M projections — a win for stop-motion animation.
- Halloween weekend (Oct 30) brings the Scream (1996) 30th-anniversary re-release, The Mongoose, Wicker expanding, and Christmas at the Kringles as the only new wide release.
- Next week is a release dead zone — Clayface could repeat at #1.
The Weekend Numbers: October 23–25, 2026
| # | Film | Weekend (Domestic) | Total Domestic | Note |
|---|
| 1 | Clayface (Warner Bros./DC) | $24.0M | $24.0M | New; 3,458 theaters; $6,940 per-screen average |
| 2 | You Can See Everything (A24) | $19.5M (+28%) | $45.1M | 2nd weekend; expanded to 2,655 theaters |
| 3 | Wildwood (Laika) | $11–11.6M | $11–11.6M | New; 2,718 venues; beat $6–8M projections |
| 4 | Street Fighter (Paramount) | $8.6M (−72%) | ~$31M | 2nd weekend; steep drop |
| 5 | Wicker (Black Bear) | $5.75–5.8M | $5.75–5.8M | New; romcom fantasy |
Figures per Box Office Mojo actuals, Deadline, Variety, and BoxOfficePro, October 26–27, 2026.
Clayface: A Modest Win That Matters More Than the Number
$24 million doesn't sound like much for a comic-book movie — and by superhero standards, it isn't. Pre-release tracking had projected $25–35 million, so Clayface opened below expectations. But the economics tell a completely different story from the headline.
The film cost a reported $30–44 million to produce — a fraction of a standard superhero tentpole. Take the top of that range: a $43–46.5 million worldwide opening weekend already exceeds the production budget. (Marketing costs and theaters' share of ticket revenue aren't in that comparison, but the math is still radically better than a $200M film opening to $60M.)
The per-screen average of $6,940 across 3,458 theaters is workable, not spectacular — but the audience response is where the real story lives:
- A− CinemaScore — excellent for horror; James Gunn noted it's one of the only horror films ever to earn an A grade, name-checking Sinners
- 75% critics / 94% audience on Rotten Tomatoes; 4.5/5 via PostTrak
- 73% of ticket buyers aged 18–34 — the demographic Hollywood covets most
- 35% Hispanic/Latino audience — an over-index that studios notice
Why it matters beyond DC: Clayface was made on the Blumhouse model — modest budget, filmmaker-driven, genre-first — rather than the superhero-tentpole model. Its opening nearly surpassed the combined debuts of Sony's villain spin-offs Kraven the Hunter ($11M) and Madame Web ($15.3M). If the lesson Hollywood takes is "smaller, better, stranger comic-book films," the genre wins even if the grosses stay modest.
The film is the third feature in the rebooted DC Universe and its first R-rated entry, directed by James Watkins and starring Tom Rhys Harries as Matt Hagen — a struggling actor whose experimental treatment gives him shapeshifting powers at the cost of his mind. No Batman appears; this isn't a superhero movie in any traditional sense. For our full take, read the Clayface full review.
The Documentary That Nearly Won: You Can See Everything
The real phenomenon of the weekend wasn't the #1 film — it was #2. A24's You Can See Everything, the Nathan Fielder and Lance Oppenheim-directed documentary about Theranos founder Elizabeth Holmes, grossed $19.5 million in its second weekend — up 28% from its debut — reaching $45.1 million total.
Second-weekend increases are rare; a documentary growing 28% while expanding from 855 to 2,655 theaters is nearly unheard of. The Hollywood Reporter called the hold remarkable. And the economics are staggering: on a reported ~$7 million budget, the film has already grossed more than six times its cost domestically.
What explains it? A perfect storm: Nathan Fielder's cult following, the endless fascination with the Theranos story, A24's marketing genius, and a three-hour runtime that turned the film into an event — something you go to, not something you stream. In an era when documentaries usually go straight to streaming, You Can See Everything is proof that theatrical documentaries can still be cultural moments.
The uncomfortable question for Clayface: the documentary earned $19.5M in weekend two — just $4.5M less than the comic-book film's opening. If You Can See Everything holds again next weekend while Clayface drops normally, the documentary could theoretically take #1 in its third weekend. That's never happened for a film like this. Watch this space.
 |
| Halloween at home: the perfect cozy movie-night setup. (AI-generated illustration) |
Wildwood: Stop-Motion's Quiet Triumph
Laika's Wildwood opened to $11–11.6 million from 2,718 venues — nearly double the $6–8 million it was projected to make. Directed by Travis Knight, the stop-motion feature also added ~$3 million from a handful of international markets, with more territories opening in the coming weeks.
In a weekend dominated by horror and documentaries, a handcrafted animated film doubling expectations is the family-audience story nobody's talking about enough. Laika has always been the critics' darling that struggles commercially; Wildwood suggests the studio's patience with the stop-motion craft is finally finding its audience. If international rollouts hold, this could become Laika's biggest film.
The Rest of the Chart: Street Fighter Falls, Wicker Opens Soft
Paramount's Street Fighter collapsed 72% in its second weekend to $8.6 million, bringing its total toward $31 million. A 72% drop is brutal by any standard — audience rejection, plain and simple. Video-game adaptations remain the most volatile genre in Hollywood: for every hit, there's a Street Fighter.
Black Bear's Wicker — the Olivia Colman and Alexander Skarsgård romcom fantasy — opened to $5.75–5.8 million. Soft, but the film expands to the UK on October 30 and Australia on November 5, so its story is just beginning. Counter-programming against horror on Halloween weekend is either brave or foolish; the UK expansion will tell us which.
And in the sad column: Klara and the Sun opened to just $720,000, and Sony has already reduced screenings. A quick trip to VOD and streaming awaits — where, as Variety notes, a viral clip could still give it a second life.
Halloween Weekend Guide: What's in Theaters October 30
Halloween falls on a Saturday this year, and theaters are programmed accordingly. Here's everything worth knowing:
Scream (1996) — 30th Anniversary Re-release. The Wes Craven classic returns to theaters for its 30th birthday. If you've never seen it on the big screen, this is the Halloween event of the year — the film that reinvented horror for a generation, still razor-sharp. Streaming after: Paramount+, Hulu, Peacock; joins HBO Max November 1.
The Mongoose (Liam Neeson). Neeson does what Neeson does — this time in a new action thriller. Counter-programming for the horror-averse; expect the usual Neeson intensity and a solid opening from his loyal audience.
Everest: The Other Side (Disney/National Geographic, IMAX). A documentary spectacle built for the biggest screen possible. If your local IMAX is showing it, that's the way to see it — mountain documentaries are the rare genre where the theater is non-negotiable.
Christmas at the Kringles. The only new wide release of the weekend — a Christmas film opening on Halloween weekend is either madness or genius. With no other wide competition, it might just work as family counter-programming.
Wicker expands (UK). The Colman/Skarsgård fantasy-romcom goes wide in Britain on October 30. UK readers: this is your weekend's wildcard.
Sense and Sensibility (Daisy Edgar-Jones). The Jane Austen adaptation arrives for the prestige crowd — the anti-Halloween option for viewers who want bonnets instead of body horror.
Still in theaters: Clayface (week 2 — could repeat #1 in the dead zone), You Can See Everything (week 3 — the one to watch), Wildwood (week 2, expanding internationally).
Halloween at Home: What to Stream
Staying in? The streaming lineup is stacked:
The Mosquito Bowl (Netflix). Netflix's big Halloween-weekend play — the streamer's attempt to own the weekend without a theatrical release.
Forgotten Island (digital, October 27). Arrived on digital this week with a 95% Rotten Tomatoes score — the best-reviewed home premiere of the weekend. If you watch one thing at home, make it this.
Scream (1996). Can't make the re-release? It's streaming on Paramount+, Hulu, and Peacock right now — and hits HBO Max on November 1. No excuse.
Clayface — not yet. Still theatrical-only; expect digital in late November or December. Don't fall for "free download" sites — they're piracy, malware, or both. (Our policy: no pirated downloads, ever.)
What the Weekend Means for Hollywood
Three takeaways from October 23–25 that will shape the industry's thinking:
1. The mid-budget film is back. Clayface ($30–44M budget, #1) and You Can See Everything (~$7M budget, $45M total) both prove the same point: audiences reward films that cost less and try more. The $200M tentpole isn't dead, but its monopoly on opening weekends is over.
2. Horror is the most reliable genre in the business. An R-rated body-horror film about a C-list Batman villain opened #1 on Halloween-adjacent weekend with an A− CinemaScore. Horror's economics — loyal audience, modest budgets, event-driven viewing — make it recession-proof in a way no other genre is. Expect more villain horror, more Blumhouse-model bets.
3. Documentaries can be events again. You Can See Everything didn't just succeed — it grew 28% in weekend two, the kind of hold usually reserved for beloved blockbusters. A24 has cracked a code: treat the documentary like a premiere, market the filmmaker like a star (Fielder), and give audiences a reason to leave the house. Every documentary distributor is taking notes.
November Preview: What's Next
After the Halloween dead zone, the holiday corridor begins. The dates to circle:
- November 20: Hunger Games: Sunrise on the Reaping — the franchise returns; the biggest pre-Thanksgiving bet on the calendar.
- November 25: Hexed — genre fare for the Thanksgiving weekend.
- Late November/December: Clayface likely hits digital — the streaming conversation starts then.
The awards corridor is also quietly loading — expect the prestige titles (Sense and Sensibility among them) to build through November toward critics' awards in December. We'll cover the contenders as they emerge.
Why $24 Million Both Disappointed and Delighted
The Clayface number needs context, because $24 million is simultaneously a miss and a triumph — and understanding both is understanding the modern box office.
The disappointment: tracking projected $25–35 million. Opening below the low end of tracking is never good news — it suggests marketing didn't fully convert awareness into ticket sales, or that the R-rating and body-horror positioning narrowed the audience more than expected. The Friday-to-Sunday trajectory ($10.6M → $7.8M → $5.6M, including $3.5M Thursday previews) shows the standard front-loaded pattern: fans showed up first, general audiences were more cautious.
The triumph: compare it to its actual peers, not to Avengers movies. Aquaman and the Lost Kingdom opened to $27.7M — barely more — on a vastly bigger budget. Blue Beetle opened to $25M. The animated DC League of Super-Pets did $23M. Clayface sits right in the DC mid-range while costing a fraction of any of them. And against Sony's villain films — Kraven ($11M), Madame Web ($15.3M) — it's a rout.
The demographic gold: 73% of buyers aged 18–34 is the stat studio executives dream about. Young audiences are the hardest to get into theaters and the most valuable when they come — they buy concessions, they post on social media, they rewatch. A film that owns the under-35 crowd has a future even with a modest opening.
The verdict the industry will remember: not the $24M, but the ratio. A $30–44M film outgrossing its budget in one weekend with an A− CinemaScore is the kind of result that greenlights the next five films like it. The number disappointed; the economics delighted. In Hollywood, economics win.
The Elizabeth Holmes Effect: Why America Can't Stop Watching
A three-hour documentary about a convicted fraudster is doing Marvel-level holds. To understand You Can See Everything, you have to understand the cultural forces behind it:
The Theranos story is America's favorite parable. A charismatic founder, fake technology, powerful enablers, a spectacular fall — it's the story Silicon Valley tells about itself when it's being honest. Every previous telling (the book Bad Blood, the podcast, the Hulu series The Dropout) found a huge audience. The documentary is the definitive visual account, and audiences are treating it as required viewing.
Nathan Fielder is a theatrical draw now. The comedian-auteur behind The Rehearsal has one of the most devoted followings in entertainment — a fanbase that treats his projects as events and evangelizes them relentlessly. Fielder's involvement turned a documentary into a happening; his fans showed up week one, and their word-of-mouth is driving week two's 28% increase.
A24 knows how to make documentaries feel like premieres. Limited initial release (855 theaters), sold-out shows, social-media buzz, then the wide expansion — the classic platform-release playbook, executed flawlessly. The 28% second-weekend jump is the reward for patience: instead of front-loading on 3,000 screens, A24 built demand and then harvested it.
The three-hour runtime helps, paradoxically. In the streaming era, length signals importance — a three-hour documentary in theaters feels like an event in a way a 90-minute one doesn't. Audiences aren't just watching a film; they're attending something. Runtime as marketing: the new theatrical playbook.
Horror's Golden Age: The Genre That Never Misses
Step back from the weekend's specifics, and Clayface is the latest data point in horror's decade-long dominance of the theatrical market. The genre's economics are unmatched:
- Modest budgets: horror films routinely cost $10–45M — a flop loses tens of millions, not hundreds
- Loyal audiences: horror fans show up opening weekend, reliably, regardless of reviews
- Event viewing: horror demands the theater — you can't replicate a screaming crowd on your couch
- Calendar power: Halloween season gives horror a built-in annual marketing hook
James Gunn's comment is telling: he noted that Sinners is the only horror film ever to get an A CinemaScore — and now Clayface has an A−. When horror films break out of the genre ghetto into genuine audience love, they overperform everything. The genre's ceiling keeps rising: Sinners, Weapons, Obsession (all name-checked in the box office analysis), and now Clayface form a new canon of critically-respected horror hits.
What this means for the industry: expect the Blumhouse model to spread beyond horror. Clayface proved a comic-book film can work at horror budgets; the next frontier is applying the formula to sci-fi, thriller, and fantasy. The $200M-everything era is ending — the future is smaller bets, stranger ideas, and better films.
Laika's Long Game: The Studio That Wouldn't Quit
Wildwood's $11M+ opening deserves a deeper appreciation, because Laika's story is one of Hollywood's great acts of stubbornness. The stop-motion studio behind Coraline, ParaNorman, The Boxtrolls, Kubo and the Two Strings, and Missing Link has spent nearly two decades making the most labor-intensive films in the industry — each second of stop-motion requires 24 individually posed frames, each frame built by hand — while the commercial rewards stayed modest.
Laika films are perennial awards favorites and perennial box office underperformers. Missing Link (2019) won the Golden Globe for Best Animated Feature and still lost money theatrically. The studio kept going anyway, funded by Nike co-founder Phil Knight's fortune and run by his son Travis Knight — a director (Bumblebee) who returned to the family business of impossible animation.
Wildwood doubling its projections suggests the patience is paying off. Audiences raised on CGI are rediscovering the tactile magic of stop-motion — in an era of AI-generated everything, the handmade has become the luxury good. If the international rollout (just beginning) holds the same momentum, Wildwood won't just be a win; it'll be the proof of concept Laika has chased for twenty years: that craft still sells.
What This Weekend Means for DC's Future
Clayface is the third film in James Gunn's rebooted DC Universe — and the experiment the whole slate is watching. The DCU's bet is that audiences want filmmaker-driven takes on characters, not universe-building homework. Clayface — R-rated, horror, no Batman, $30–44M budget — is the purest expression of that bet.
The result validates the strategy's economics, if not its scale. A $24M opening doesn't launch a universe; but a profitable $24M opening on a $40M film is a better business than a $60M opening on a $200M film. Gunn's public pride (the Threads post about the A− CinemaScore) signals the studio sees it the same way: quality first, universe second.
What comes next: The Penguin's success on television already proved the villain-spin-off model works; Clayface proves it works theatrically at the right budget. Expect the Poison Ivy project (and other villain films) to move forward with similar Blumhouse-model economics — modest budgets, strong filmmakers, genre-first storytelling.
The risk: if every DC film becomes a $40M genre piece, the universe loses its event-movie wing. The trick is balance — tentpoles for the team-ups, auteur films for the characters. Clayface suggests DC finally understands the assignment.
The International Picture
Domestic numbers tell half the story. Internationally:
- Clayface: $19–22.5M from 76 markets — a solid but unspectacular international start. Horror travels less well than action; cultural differences in horror taste and the R-rating's equivalent restrictions limit the ceiling. The worldwide $43–46.5M total is good, not great.
- Wildwood: ~$3M from a handful of markets — just beginning its rollout. Animation travels well; Laika's international performance will decide whether this is a hit or a phenomenon. Watch the UK, France, and Japan numbers especially.
- You Can See Everything: domestic-focused so far. Documentaries about American corporate fraud have limited international appeal — but A24's brand travels, and Fielder's global cult following could surprise.
The pattern: mid-budget films increasingly live or die domestically, while tentpoles need the world. Clayface's economics work even with a modest international run — another advantage of the small-budget model.
The A24 Playbook: Platform-Releasing in 2026
You Can See Everything's 28% second-weekend jump deserves a case study, because A24 just demonstrated the platform release done right — a strategy most studios have abandoned as too slow for the modern market.
Week one: scarcity. 855 theaters, sold-out shows in major markets, the film as a rumor you had to chase. Social media did the marketing: Fielder's fans posted ticket stubs like concert tickets, turning attendance into identity.
Week two: harvest. Expansion to 2,655 theaters met demand the first week created. The 28% increase isn't just growth — it's proof the demand was real and pent-up, not manufactured. Most wide releases lose 50–60% in week two; growing 28% while tripling the theater count is the kind of result distribution executives frame.
Why others can't copy it easily: the playbook needs three ingredients A24 uniquely has — a filmmaker with a cult (Fielder), a subject with built-in fascination (Holmes/Theranos), and a brand audiences trust (A24). Remove any one, and the platform release becomes a slow death instead of a coronation. But the lesson is transferable: patience beats saturation when the product is genuinely special.
For Pakistan and Regional Readers
Box office stories are Hollywood-centric, but the ripples reach everywhere:
Clayface's model matters for global cinema. The Blumhouse-model success — modest budget, genre-first, filmmaker-driven — is replicable in film industries without Hollywood budgets, including Pakistan's. The lesson isn't "make superhero horror"; it's "match the budget to the story and let the filmmaker cook." That's universal.
The documentary boom is a streaming story here. You Can See Everything may never get a Pakistani theatrical release, but its eventual streaming arrival will be an event — A24 documentaries travel well on streaming, and the Theranos story has global fascination. Watch for it.
Halloween viewing is a global ritual now. Whether it's the Scream re-release (check local listings), Forgotten Island on digital, or a horror marathon at home — the Halloween watch guide works wherever you are. Horror is the most global genre: fear needs no translation.
Frequently Asked Questions
How much did Clayface make opening weekend?
$24 million domestic (3,458 theaters, October 23–25, 2026) and $43–46.5 million worldwide, on a reported $30–44 million production budget. Below the $25–35M tracking, but profitable on its mid-budget economics.
Is Clayface a hit or a flop?
A modest hit. The $24M opening underwhelmed versus tracking, but the budget was small, audiences loved it (A− CinemaScore, 94% audience score), and the worldwide opening already covers the production cost. By the Blumhouse-model math DC used, it's a win — and it validates smaller comic-book films.
What is You Can See Everything about?
A24's three-hour documentary about Theranos founder Elizabeth Holmes, directed by Nathan Fielder and Lance Oppenheim. It made $19.5M in its second weekend (+28%) for a $45.1M total on a ~$7M budget — one of the biggest documentary runs in years.
Will Clayface be #1 again on Halloween weekend?
Possibly. Next week is a new-release dead zone — the only wide opener is Christmas at the Kringles — so a normal second-weekend hold could keep Clayface on top. The threat is You Can See Everything: if the documentary holds again, it could theoretically take #1 in its third weekend.
Where can I watch Scream (1996)?
In theaters now for the 30th-anniversary re-release, or streaming on Paramount+, Hulu, and Peacock — it joins HBO Max on November 1.
When will Clayface be streaming?
Not yet announced. Still theatrical-only; expect digital in late November or December 2026. Avoid "free download" sites — they're piracy and often malware.
What should I watch on Halloween night?
In theaters: the Scream re-release (the event pick) or Clayface week 2. At home: Forgotten Island (95% RT, new on digital) or Scream (1996) streaming. With family: Wildwood in theaters or Christmas at the Kringles.
Is Wildwood appropriate for kids?
Yes — it's Laika's family stop-motion feature, and it's the weekend's best family option in theaters. It doubled its projections on word-of-mouth, which is the strongest family-film signal there is.
Why did Street Fighter flop?
A 72% second-weekend drop to $8.6M signals outright audience rejection — bad word-of-mouth, bad reviews, or both. Video-game adaptations remain Hollywood's most volatile genre: the highs are high, but the floor is a trapdoor.
The Complete Halloween Weekend Schedule
Friday, October 30: Scream 30th-anniversary re-release opens; The Mongoose, Everest: The Other Side (IMAX), Christmas at the Kringles, and Sense and Sensibility arrive; Wicker expands in the UK. The busiest moviegoing Friday of the fall.
Saturday, October 31 — Halloween: Peak horror day. Theaters will be packed for evening shows — book Scream or Clayface tickets in advance. At home: The Mosquito Bowl premieres on Netflix; Forgotten Island is fresh on digital.
Sunday, November 1: Scream (1996) joins HBO Max — the streaming option for everyone who missed the re-release. Box office analysts will be watching whether Clayface or the documentary takes the weekend.
Monday, November 2: Weekend actuals arrive — we'll have the answer to the Clayface vs. You Can See Everything rematch. Check back for our breakdown.
Glossary: Box Office Terms in This Article
Domestic box office: Ticket sales in the US and Canada. Clayface's $24M is its domestic opening.
Per-screen average (PSA): Weekend gross divided by theater count. $6,940 for Clayface — solid, not spectacular.
CinemaScore: Opening-night audience polling, graded A+ to F. A− is excellent for horror.
Tracking: Pre-release projections. Clayface was tracked at $25–35M; it opened at $24M — a miss.
Hold: How well a film retains its audience week to week. You Can See Everything's +28% second weekend is an extraordinary hold.
Platform release: Opening in limited theaters, then expanding. A24's strategy for the documentary — 855 → 2,655 theaters.
The Race to Watch: Clayface vs. The Documentary, Round Two
Halloween weekend sets up the most interesting box office battle of the fall. On one side: Clayface, the #1 film, entering its second weekend with strong audience scores and a dead zone of new competition. On the other: You Can See Everything, the documentary that grew 28% in weekend two and sits at $45.1M — just $4.5M behind Clayface's opening.
The math: a typical horror second weekend drops 55–65%. On $24M, that puts Clayface's weekend two at roughly $8.5–11M. For the documentary to win, it needs to hold near $19.5M or grow again in weekend three — unprecedented, but this film has already done the unprecedented twice.
The Halloween factor: horror overperforms on Halloween weekend — the calendar is Clayface's best friend. Families and date-night audiences lean spooky, and the Scream re-release will pull some horror dollars away from both contenders. Our prediction: Clayface repeats at #1 with ~$10M, the documentary takes #2 with a historic hold, and the story becomes "the $7M documentary that wouldn't die."
Either way, the real winner is the mid-budget film. Two movies made for under $50M combined are dominating the conversation while $200M tentpoles sit out the weekend. That's not a fluke — it's the future.
The Bottom Line
The October 23–25 weekend was the healthiest box office story of the fall: a $24M R-rated horror film winning on mid-budget economics, a $7M documentary growing 28% in its second weekend toward $45M, and a stop-motion film doubling its projections. Every winner was a film that cost less and tried more — the exact opposite of the tentpole formula that has dominated Hollywood for two decades.
Halloween weekend offers the perfect follow-up: a Scream anniversary celebration, a potential Clayface repeat, and a documentary that might just steal the crown in week three. Whether you're in a theater seat or on your couch, it's a great weekend to be a movie fan — and a fascinating one to watch as an industry observer.
Our full Halloween weekend box office breakdown arrives early next week — the Clayface vs. documentary rematch is the race to watch. And beyond the numbers, the weekend's real legacy is the template: smaller budgets, stranger ideas, filmmaker trust, and audiences rewarded with films that feel made by humans rather than committees. In an era of AI-generated everything, the most valuable thing in cinema might be the thing Clayface, the documentary, and Wildwood all share — the unmistakable feeling that a person made this, on purpose, for you — and that feeling is exactly why theaters still matter.
p>
Is Clayface connected to The Batman or the old DCEU?
No. It's the third film in James Gunn's rebooted DC Universe — a fresh continuity.
Bruce Wayne doesn't appear; the film stands alone as a horror story. You need no prior DC knowledge to watch it.
How long is You Can See Everything?
Three hours. The runtime is part of the event strategy — length signals importance in the streaming era, and audiences are treating it as a theatrical happening, not content.
What's the best box office tracking site for following these numbers?
Box Office Mojo for actuals, Deadline and Variety for weekend reporting, and BoxOfficePro for analysis. Weekend estimates land Sunday, actuals Monday — we used actuals wherever available in this article.
How We Verified This Article
- Weekend grosses: Box Office Mojo actuals ($24,002,731 for Clayface), Deadline ($24.5M Sunday estimate), Variety, BoxOfficePro, and NewsCubby — all from October 26–27, 2026; ranges reflect estimate-vs-actual differences.
- Budgets: Clayface $30–44M (multiple outlets), documentary ~$7M (ComicBookCo) — reported figures, not studio confirmations; ranges stated honestly.
- Audience data: A− CinemaScore, 75%/94% Rotten Tomatoes, PostTrak 4.5/5, demographic breakdowns — via BoxOfficePro and Badiyaa's opening-weekend analysis.
- Halloween slate: Scream re-release, The Mongoose, Everest: The Other Side, Christmas at the Kringles, Sense and Sensibility, Wicker UK expansion, The Mosquito Bowl, Forgotten Island digital — from the October 2026 release calendar; streaming dates as announced.
What we didn't do: present estimates as actuals, invent audience reactions, or link to pirated copies. Box office figures are estimates until final actuals; we used actuals where available.
Sources
AI Tech Hub is an independent publication. Box office figures are reported estimates/actuals from October 26–27, 2026, and are subject to revision. Film titles belong to their respective studios.
Comments
Post a Comment